Related references
Note: Only part of the references are listed.Costos directos de la artritis reumatoide temprana en el primer año de atención: simulación de tres situaciones clínicas en un hospital universitario de tercer nivel en Colombia
Gerardo Quintana et al.
Biomedica (2014)
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice
M. Neovius et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Martin Neovius et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)
J. Augustsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The value of productivity: human-capital versus friction-cost method
W. B. van den Hout
ANNALS OF THE RHEUMATIC DISEASES (2010)
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study
Tor Olofsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Socioeconomic impact of ankylosing spondylitis in Tunisia
Mohamed Younes et al.
JOINT BONE SPINE (2010)
Socioeconomic Burden of Psoriatic Arthritis in Hong Kong: Direct and Indirect Costs and the Influence of Disease Pattern
Tracy Y. Zhu et al.
JOURNAL OF RHEUMATOLOGY (2010)
Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study
Eiichi Tanaka et al.
MODERN RHEUMATOLOGY (2010)
Annual costs of rheumatoid arthritis in Turkey
Simten Malhan et al.
RHEUMATOLOGY INTERNATIONAL (2010)
European biologicals registers: methodology, selected results and perspectives
A. Zink et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
M. T. Halpern et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Measuring Worker Productivity: Frameworks and Measures
Dorcas Beaton et al.
JOURNAL OF RHEUMATOLOGY (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Disease status, costs and quality of life of patients with rheumatoid arthritis in France: The ECO-PR Study
Gisela Kobelt et al.
JOINT BONE SPINE (2008)
The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit
R. M. Ara et al.
RHEUMATOLOGY (2008)
Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patients perspective
T. Mittendorf et al.
RHEUMATOLOGY (2008)
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments
G. Kobelt et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2008)
Trends in economic consequences of rheumatoid arthritis over two subsequent years
S. M. M. Verstappen et al.
RHEUMATOLOGY (2007)
Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany
D. Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)
E Hallert et al.
RHEUMATOLOGY (2006)
Cost effectiveness of tumour necrosis factor-alpha inhibitors as first-line agents in rheumatoid arthritis
James R. Spalding et al.
PHARMACOECONOMICS (2006)
Systematic review of studies of productivity loss due to rheumatoid arthritis
W Burton et al.
OCCUPATIONAL MEDICINE-OXFORD (2006)
Share Paper
